Angiotensin ii in atrial structural remodeling: The role of ang II/JAK/STAT3 signaling pathway

American Journal of Translational Research

Volumn 7, Issue 6, 2015, Pages 1021-1031

  Zheng, Liuying ^a   Jia, Xiaogang ^a   Zhang, Cheng ^a   Wang, Dong ^a   Cao, Zhongnan ^a   Wang, Jin ^b   Du, Xinping ^a  

^a TIANJIN FIFTH CENTRAL HOSPITAL   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Ang II JAK STAT3 pathway; Angiotensin II; Atrial fibrillation; Atrial structural remodeling; STAT

Indexed keywords

ANGIOTENSIN II; BETA ACTIN; CASPASE 3; CASPASE 8; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOCHROME C; GELATINASE A; INTERSTITIAL COLLAGENASE; JANUS KINASE; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ATRIUM REMODELING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PERSISTENT ATRIAL FIBRILLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUNEL ASSAY; WESTERN BLOTTING;

ANIMALIA; RATTUS;

EID: 84939536062     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802-809.
2. Muntean DM, Kohajda Z, Fazekas T, Jost N. Atrial Remodeling in Permanent Atrial Fibrillation: Mechanisms and Pharmacological Implications. J Clin Exp Cardiolog 2013; 4: 11.
3. Pandit SV, Jalife J. Rotors and the dynamics of cardiac fibrillation. Circ Res 2013; 112: 849-862.
4. Schotten U, Neuberger HR, Allessie MA. The role of atrial dilatation in the domestication of atrial fibrillation. Prog Biophys Mol Biol 2003; 82: 151-162.
5. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-1184.
6. Tsai CT, Tseng CD, Hwang JJ, Wu CK, Yu CC, Wang YC, Chen WP, Lai LP, Chiang FT, Lin JL. Tachycardia of atrial myocytes induces collagen expression in atrial fibroblasts through transforming growth factor ß1. Cardiovasc Res 2011; 89: 805-815.
7. Xu J, Cui G, Esmailian F, Plun-kett M, Marelli D, Ardehali A, Odim J, Laks H, Sen L. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004; 109: 363-368.
8. Grammer JB, Bohm J, Dufour A, Benz M, Lange R and Bauernschmitt R. Atrial fibrosis in heart surgery patients decreased collagen III/I ratio in postoperative atrial fibrillation. Basic Res Cardiol 2005; 100: 288-294.
9. Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens 1998; 16: 1031-1041.
10. Tan AY, Zimetbaum P. Atrial fibrillation and atrial fibrosis. J Cardiovasc Pharmacol 2011; 57: 625-629.
11. Evans RA, Tian YC, Steadman R, Phillips AO. TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of SMAD proteins. Exp Cell Res 2003; 282: 90-100.
12. Chen K, Mehta JL, Li D, Joseph L, Joseph J. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res 2004; 95: 1167-1173.
13. Tokuda K, Kai H, Kuwahara F, Yasukawa H, Tahara N, Kudo H, Takemiya K, Koga M, Yamamoto T, Imaizumi T. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis. Hypertension 2004; 43: 499-503.
14. Aharinejad S, Krenn K, Paulus P, Schäfer R, Zuckermann A, Grimm M, Abraham D. Differential role of TGFbeta1/bFGF and ET-1 in graft fibrosis in heart failure patients. Am J Transplant 2005; 5: 2185-2192.
15. Tsai CT, Lai LP, Kuo KT, Hwang JJ, Hsieh CS, Hsu KL, Tseng CD, Tseng YZ, Chiang FT, Lin JL. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 2008; 117: 344-355.
16. Disertori M, Barlera S, Staszewsky L, Latini R, Quintarelli S, Franzosi MG. Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope. Cardiovasc Drugs Ther 2012; 26: 47-54.
17. Aimé-Sempé C, Folliguet T, Rücker-Martin C, Krajewska M, Krajewska S, Heimburger M, Aubier M, Mercadier JJ, Reed JC, Hatem SN. Myocardial cell death in fibrillation and dilated human right atria. J Am Coll Cardiol 1999; 24: 77-82.
18. Goette A, Juenemann G, Peters B, Klein HU, Roessner A, Huth C, Röcken C. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovasc Res 2002; 54: 390-396.
19. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythmia Electrophysiol 2008; 1: 62-73.
20. Nattel S, Maguy A, Le Bouter S, Yeh YH. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 2007; 87: 425-456.
21. Nakano Y, Niida S, Dote K, Takenaka S, Hirao H, Miura F, Ishida M, Shingu T, Sueda T, Yoshizumi M, Chayama K. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol 2004; 43: 818-825.
22. Anné W, Willems R, Roskams T, Sergeant P, Herijgers P, Holemans P, Ector H, Heidbüchel H. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res 2005; 67: 655-666.
23. Mukherjee R, Herron AR, Lowry AS, Stroud RE, Stroud MR, Wharton JM, Ikonomidis JS, Crumbley AJ, Spinale FG, Gold MR. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol 2006; 97: 532- 537.
24. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 2002; 90: 520-530.
25. de Jong S, van Veen TA, van Rijen HV, de Bakker JM. Fibrosis and cardiac arrhythmias. J Cardiovasc Pharmacol 2011; 57: 630-638.
26. Kallergis EM, Goudis CA, Kanoupakis EM, Mavrakis HE, Maliaraki NE, Tzanakis N, Vardas PE. Sinus rhythm restoration affects collagen turnover in patients with persistent atrial fibrillation. Europace 2014; 16: 1726-1730.
27. Löfsjögård J, Persson H, Díez J, López B, González A, Edner M, Mejhert M, Kahan T. Atrial fibrillation and biomarkers of myocardial fibrosis in heart failure. Scand Cardiovasc J 2014; 48: 299-303.